Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes

Clinical Diabetes - United States
doi 10.2337/diaclin.33.1.5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association